L187V

General Information


DRACP ID  DRACP00848

Peptide Name   L187V

Sequence  GCRVYGFKIHGCG

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Hep-G2 Hepatoblastoma; Hepatoblastoma Blastoma IC50=38.9 µM CCK-8 assay 48h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Protein kinase CK2

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00848

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys2<--->Cys12

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C61H93N19O15S2

Absent amino acids  ADELMNPQSTW

Common amino acids  G

Mass  161088

Pl  8.8

Basic residues  3

Acidic residues  0

Hydrophobic residues  3

Net charge  3

Boman Index  -701

Hydrophobicity  15.38

Aliphatic Index  52.31

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1615

Absorbance 280nm  134.58

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30307134

Title  Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity

Doi 10.1002/minf.201800089

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.